Hormonal Contraception and Risk of Chlamydia and Gonorrhea
Status:
Terminated
Trial end date:
2001-08-01
Target enrollment:
Participant gender:
Summary
There are biological reasons to suspect that hormones may affect the risk of a woman becoming
infected with a sexually transmitted disease. The evidence on this issue to date is mixed and
previous studies have methodologic flaws making it difficult to draw conclusions about the
results.
This study compares the risk of developing either Chlamydial or Gonorrheal infection among
three groups of women: those using combined oral contraceptives (birth control pills); those
using the injectable hormone (brand name Depo Provera); and those women using non-hormonal
contraceptive methods.
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)